Results 121 to 130 of about 830 (135)
Some of the next articles are maybe not open access.

Effects of pentadecapeptide BPC-157 on rat calvarial bicortical defects

2003
Gastric pentadecapeptide BPC-157 (currently in clinical phase II for inflammatory bowel disease) was tested in 7 mm diameter surgically created defects of rat calvaria. Insufficient or absence of bone healing is a frequent problem within all surgical fields.
Dobric, Ivan   +16 more
openaire   +2 more sources

Pentadecapeptide BPC 157 and Rac 1 inhibitors

2016
UVOD: Rac1 je mali signalizirajući G-protein koji može aktivirati NF-kappaB. Pentadekapeptid BPC 157 smanjuje transkripciju Vcam-1 u NF-kappaB signalnom putu kao i neki NF-kappaB inhibitori te suprimira da ERK inducira Vcam-1 preko NF-kappaB aktivacije.
openaire  

Beneficial effect of BPC-157 on cardiovascular stress

2016
U radu se opisuju učinci pentadekapeptida BPC 157 na razne modele stresa u kardiovaskularnim eksperimentalnim modelima.
openaire   +1 more source

Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation

European Journal of Pharmacology, 2019
Marijana Coric   +2 more
exaly  

Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: A relation with NO-system

Regulatory Peptides, 2009
Marijana Coric   +2 more
exaly  

The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks

Journal of Physiology (Paris), 1997
Predrag Sikiric   +2 more
exaly  

Home - About - Disclaimer - Privacy